ELISA methodology for detection of modified osteoprotegerin in clinical studies

Clinical Chemistry

Volumn 47, Issue 4, 2001, Pages 747-749

  Chen, D ^a   Sarikaya, N A ^a   Gunn, H ^a   Martin, S W ^a   Young, J D ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMGN 0007; HUMAN SERUM ALBUMIN; MONOCLONAL ANTIBODY; OSTEOPROTEGERIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CALCIFICATION; CALIBRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; OSTEOCLAST; OSTEOPOROSIS; QUALITY CONTROL;

EID: 0035057122     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.4.747     Document Type: Article

References (21)

1. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
2. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
3. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
4. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenic protein-2, and cytokines
5. Estrogen stimulates gene expression and protein production of osteoprotegerin by human osteoblastic cells
6. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
7. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
8. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymphnode organogenesis
9. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: Increased serum concentrations in postmenopausal women with osteoporosis
10. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors
11. Osteoclast differentiation factor is a ligand for osteoprotegerin/oscteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL
12. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
13. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
14. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
15. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts
16. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
17. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor
18. Endogenous interference in immunoassays in clinical chemistry. A review